Live Breaking News & Updates on Portuguese health authority

Stay informed with the latest breaking news from Portuguese health authority on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Portuguese health authority and stay connected to the pulse of your community

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and

LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical...

Australia , Lisbon , Lisboa , Portugal , Germany , Nataliia-garnina , Anton-nakhodkin , Michael-sassano , Portuguese-health-authority , Pharmaceuticals-unipessoal , Pharmaceuticals-ltd , Board-member

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

Somai GMP Facility Somai GMP Facility LISBON, Portugal, Sept. 01, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (the “Company” or “SOMAÍ”), the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation for its facility located in Lisbon, Portugal from the Portuguese Health Authority INFRAMED (authorisation number 42/V01 de 25/08/2023). This authorisation permits the Company to manufacture, import, and export medicinal

Portugal , Australia , Lisbon , Lisboa , Germany , Nataliia-garnina , Michael-sassano , Anton-nakhodkin , Pharmaceuticals-unipessoal , Pharmaceuticals-ltd , Portuguese-health-authority , Board-member

Somaí Pharmaceuticals Receives Eu-Gmp Certification And Raises €5 Million

Somaí Pharmaceuticals Receives Eu-Gmp Certification And Raises €5 Million
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Portugal , Australia , Lisbon , Lisboa , Germany , Nataliia-garnina , Michael-sassano , Anton-nakhodkin , Portuguese-health-authority , Pharmaceuticals-ltd , Pharmaceuticals-unipessoal , Board-member

From Manufacturing To Market: How This EU Pharma Co. Fast-Tracked Cannabis Production

European pharmaceutical cannabis product manufacturer SOMAÍ Pharmaceuticals Unipessoal LDA received authorization for its facility in Lisbon, Portugal, from the Portuguese Health Authority INFRAMED. Why It Matters This authorization allows the company to produce, import, and export medicinal cannabis products to numerous global markets.

Germany , Portugal , Australia , Lisbon , Lisboa , Chicago , Illinois , United-states , Anton-nakhodkin , Michael-sassano , Portuguese-health-authority , Pharmaceuticals-unipessoal

Cureus | SARS-CoV-2 Antibody Seroprevalence in Patients With Cancer on Systemic Antineoplastic Treatment in the First Wave of the COVID-19 Pandemic in Portugal

At the time of the first wave of the COVID-19 pandemic, patients with cancer were considered to be at high risk of serious illness and had a higher exposure risk since they needed frequent and nondeferrable hospital visits. Serological tests were not routinely used, and seroprevalence in this population was unknown.

A single-center, cross-sectional study was developed to determine the seroprevalence of anti-SARS-CoV-2 antibodies (Abs) in patients with cancer undergoing systemic antineoplastic treatment. One hundred patients were consecutively recruited in a two-week period (6th-20th May 2020), and serum samples were tested for the presence of immunoglobulin M (IgM) and immunoglobulin G (IgG) Abs directed against both spike (S) and nucleocapsid (N) SARS-CoV-2 proteins in two distinct time points (at recruitment and 4-8 weeks later). IgG-positive results were subject to confirmation, in the same serum sample, using two distinct assays.

At the time of the first study visit, no patient had a previously confirmed diagnosis of COVID-19, one reported previous contact with a COVID-19 patient, and all had a baseline SARS-CoV-2-negative RT-PCR. Two patients tested positive for SARS-CoV-2 IgG in the first study visit, which was not confirmed in either of the two confirmatory assays. Seventy-two patients were tested at the second study visit, all with negative IgG tests. IgM was persistently positive at both study visits in one patient and was positive in another patient at the second study visit, both with negative RT-PCR and serum IgG. No patient tested positive for RT-PCR within the study timeframe.

No evidence of prior or acute SARS-CoV-2 infection was documented in this cohort of patients with cancer undergoing systemic treatment, and no additional exposure risk was documented compared to general population seroprevalence studies. The study was inconclusive regarding the role of SARS-CoV-2 serology in patients with cancer in the early phase of the pandemic. This study did show that, with adherence to recommended preventive measures, it was safe to maintain systemic cancer therapy.

Wuhan , Hubei , China , United-states , Shenzhen , Guangdong , Italy , Geneva , Genè , Switzerland , Portugal , Austria

Corona-News: Laschet lehnt Impfpflicht in Deutschland weiter ab

Corona-News: Laschet lehnt Impfpflicht in Deutschland weiter ab
web.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from web.de Daily Mail and Mail on Sunday newspapers.

Hanover , Niedersachsen , Germany , Australia , New-zealand , Borneo , Indonesia-general- , Indonesia , United-kingdom , Portugal , France , Lower-saxony

Coronavirus-Liveticker: +++ 13:58 Sydney lockert Corona-Regeln – für Geimpfte +++

Coronavirus-Liveticker: +++ 13:58 Sydney lockert Corona-Regeln – für Geimpfte +++
n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Rosenheim , Rheinland-pfalz , Iraq , New-zealand , Schleswig , Schleswig-holstein , Italy , Portugal , France , Lower-saxony

Coronavirus-Liveticker: +++ 14:21 Griechenland verschärft Testpflicht für Ungeimpfte +++

Coronavirus-Liveticker: +++ 14:21 Griechenland verschärft Testpflicht für Ungeimpfte +++
n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Rosenheim , Rheinland-pfalz , Iraq , New-zealand , Schleswig , Schleswig-holstein , Italy , Portugal , France , Lower-saxony

Coronavirus-Liveticker: +++ 14:44 Großbritannien löst Vertrag mit Impfstoffhersteller Valneva auf +++

Coronavirus-Liveticker: +++ 14:44 Großbritannien löst Vertrag mit Impfstoffhersteller Valneva auf +++
n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Rosenheim , Rheinland-pfalz , Iraq , New-zealand , Schleswig , Schleswig-holstein , United-kingdom , Italy , Portugal , France

Corona-Ticker: 90 Prozent der Intensivpatienten ungeimpft

Corona-Ticker: 90 Prozent der Intensivpatienten ungeimpft
br.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from br.de Daily Mail and Mail on Sunday newspapers.

Germany , Australia , New-zealand , United-kingdom , Italy , China , Portugal , France , Berlin , Lower-saxony , Niedersachsen , Italian